 Connection
Marilyn Manco-Johnson to Risk
This is a "connection" page, showing publications Marilyn Manco-Johnson has written about Risk.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.146 |
|
|
|
-
Goldenberg NA, Bernard TJ, Hillhouse J, Armstrong-Wells J, Galinkin J, Knapp-Clevenger R, Jacobson L, Marcovina SM, Manco-Johnson MJ. Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children. Haematologica. 2013 May; 98(5):802-7.
Score: 0.079
-
Manco-Johnson MJ. Risk of stratified therapies for antiphospholipid antibody syndrome (APS) in pregnancy: is tailored treatment ready for prime time? J Thromb Haemost. 2005 Feb; 3(2):240-2.
Score: 0.045
-
Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio A, Journeycake J, Junker R, Male C, Manco-Johnson M, Massicotte P, Mesters R, Monagle P, van Ommen H, Rafini L, Simioni P, Young G, Nowak-Göttl U. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost. 2011 Oct; 37(7):802-9.
Score: 0.018
-
Shapiro AD, Jacobson LJ, Armon ME, Manco-Johnson MJ, Hulac P, Lane PA, Hathaway WE. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr. 1986 Oct; 109(4):675-80.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|